The vascular imaging devices market size has grown strongly in recent years. It will grow from $8.4 billion in 2025 to $8.89 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, expansion of diagnostic imaging infrastructure, adoption of ultrasound and angiography systems, increased use of hospital-based imaging services, availability of trained radiology professionals.
The vascular imaging devices market size is expected to see strong growth in the next few years. It will grow to $11.12 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing demand for early disease detection, rising investments in advanced imaging technologies, expansion of outpatient diagnostic centers, growing integration of imaging with digital health platforms, development of portable vascular imaging devices. Major trends in the forecast period include increasing integration of ai-based image analysis, rising adoption of non-invasive vascular imaging techniques, growing use of high-resolution imaging modalities, expansion of minimally invasive diagnostic procedures, enhanced focus on early cardiovascular diagnosis.
The rising prevalence of diabetes and hypertension is expected to drive the growth of the vascular imaging devices market going forward. Diabetes is a chronic metabolic disorder in which the body cannot produce or properly use insulin, while hypertension is characterized by persistently high arterial blood pressure that strains the vascular system. The increase in these conditions is fueled by aging populations, rising obesity rates, sedentary lifestyles, and unhealthy dietary habits. Vascular imaging supports clinical management by enabling early detection and continuous monitoring of vascular changes associated with diabetes and hypertension, facilitating timely evaluation of disease progression and treatment planning. For instance, in September 2025, according to the World Health Organization, a Switzerland-based international public health agency, 1.4 billion adults aged 30-79 worldwide had hypertension in 2024, with only 23% achieving controlled blood pressure. Therefore, the growing prevalence of diabetes and hypertension is driving the growth of the vascular imaging devices market.
Major companies operating in the vascular imaging devices market are focusing on developing next-generation intravascular ultrasound (IVUS) platforms enhanced with artificial intelligence to address the limitations of legacy systems. Next-generation IVUS platforms are sophisticated imaging tools that deliver high-resolution, real-time cross-sectional images of blood vessels, improving diagnostic accuracy, guiding interventions, and optimizing cardiovascular treatments. For instance, in October 2023, Evident Vascular Inc., a US-based med-tech company, emerged from stealth with $35 million in Series A financing to develop an advanced IVUS platform. This innovation surpasses older IVUS systems by offering superior image interpretation, streamlined workflow, and improved adoption in peripheral vascular procedures through AI-driven analysis. Supported by Vensana Capital, Evident Vascular’s technology is initially targeted for peripheral arteries, with future applications planned for coronary interventions.
In September 2024, Boston Scientific Corporation, a medical technology company based in the US, acquired Silk Road Medical, Inc. for $1.28 billion. This acquisition enhances Boston Scientific's vascular portfolio, enabling the company to offer comprehensive solutions for physicians treating peripheral vascular diseases. Silk Road Medical's technology supports minimally invasive procedures, which can shorten recovery times and reduce complications compared to traditional open surgery methods. Silk Road Medical, a US-based medical device company, specializes in creating and manufacturing devices for treating carotid artery diseases, particularly through its innovative Transcarotid Artery Revascularization (TCAR) platform.
Major companies operating in the vascular imaging devices market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Terumo Corporation, Nipro Corporation, Shimadzu Corporation, Bracco Group, Carestream Health Inc., Hitachi Medical Corporation, Canon Medical Systems Corporation, Toshiba Medical Systems Corporation, Christie Medical Holdings Inc., Fujifilm Healthcare Corporation, Esaote SpA, Mindray Medical International Limited, Ziehm Imaging GmbH, Samsung Medison Co. Ltd., United Imaging Healthcare.
North America was the largest region in the vascular imaging devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular imaging devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular imaging devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the vascular imaging devices market by increasing costs of imported sensors, imaging probes, semiconductor chips, high-resolution displays, and advanced computing components. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported high-end imaging systems, while Asia-Pacific faces cost pressures on device manufacturing and exports. These tariffs are elevating equipment acquisition costs and delaying technology upgrades. However, they are also promoting local assembly, regional manufacturing partnerships, and increased investment in domestic imaging technology capabilities.
The vascular imaging devices market research report is one of a series of new reports that provides vascular imaging devices market statistics, including vascular imaging devices industry global market size, regional shares, competitors with a vascular imaging devices market share, detailed vascular imaging devices market segments, market trends and opportunities, and any further data you may need to thrive in the vascular imaging devices industry. This vascular imaging devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Vascular imaging devices are medical tools that employ non-invasive techniques to visualize blood vessels and the circulatory system. They use various technologies to produce detailed images of the vascular network, assisting in the diagnosis and treatment of cardiovascular issues.
The primary categories of vascular imaging devices are minimally invasive and non-invasive. Minimally invasive procedures involve small incisions or catheters to access internal structures for diagnostic or therapeutic purposes. These devices are used in a range of applications, including diagnostics and treatment, serving end-users such as hospitals, diagnostic imaging centers, and other medical facilities.
The vascular imaging devices market consists of sales of angiography systems, intravascular ultrasound systems, high-speed computed tomography systems, and portable doppler devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The vascular imaging devices market size is expected to see strong growth in the next few years. It will grow to $11.12 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to increasing demand for early disease detection, rising investments in advanced imaging technologies, expansion of outpatient diagnostic centers, growing integration of imaging with digital health platforms, development of portable vascular imaging devices. Major trends in the forecast period include increasing integration of ai-based image analysis, rising adoption of non-invasive vascular imaging techniques, growing use of high-resolution imaging modalities, expansion of minimally invasive diagnostic procedures, enhanced focus on early cardiovascular diagnosis.
The rising prevalence of diabetes and hypertension is expected to drive the growth of the vascular imaging devices market going forward. Diabetes is a chronic metabolic disorder in which the body cannot produce or properly use insulin, while hypertension is characterized by persistently high arterial blood pressure that strains the vascular system. The increase in these conditions is fueled by aging populations, rising obesity rates, sedentary lifestyles, and unhealthy dietary habits. Vascular imaging supports clinical management by enabling early detection and continuous monitoring of vascular changes associated with diabetes and hypertension, facilitating timely evaluation of disease progression and treatment planning. For instance, in September 2025, according to the World Health Organization, a Switzerland-based international public health agency, 1.4 billion adults aged 30-79 worldwide had hypertension in 2024, with only 23% achieving controlled blood pressure. Therefore, the growing prevalence of diabetes and hypertension is driving the growth of the vascular imaging devices market.
Major companies operating in the vascular imaging devices market are focusing on developing next-generation intravascular ultrasound (IVUS) platforms enhanced with artificial intelligence to address the limitations of legacy systems. Next-generation IVUS platforms are sophisticated imaging tools that deliver high-resolution, real-time cross-sectional images of blood vessels, improving diagnostic accuracy, guiding interventions, and optimizing cardiovascular treatments. For instance, in October 2023, Evident Vascular Inc., a US-based med-tech company, emerged from stealth with $35 million in Series A financing to develop an advanced IVUS platform. This innovation surpasses older IVUS systems by offering superior image interpretation, streamlined workflow, and improved adoption in peripheral vascular procedures through AI-driven analysis. Supported by Vensana Capital, Evident Vascular’s technology is initially targeted for peripheral arteries, with future applications planned for coronary interventions.
In September 2024, Boston Scientific Corporation, a medical technology company based in the US, acquired Silk Road Medical, Inc. for $1.28 billion. This acquisition enhances Boston Scientific's vascular portfolio, enabling the company to offer comprehensive solutions for physicians treating peripheral vascular diseases. Silk Road Medical's technology supports minimally invasive procedures, which can shorten recovery times and reduce complications compared to traditional open surgery methods. Silk Road Medical, a US-based medical device company, specializes in creating and manufacturing devices for treating carotid artery diseases, particularly through its innovative Transcarotid Artery Revascularization (TCAR) platform.
Major companies operating in the vascular imaging devices market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Terumo Corporation, Nipro Corporation, Shimadzu Corporation, Bracco Group, Carestream Health Inc., Hitachi Medical Corporation, Canon Medical Systems Corporation, Toshiba Medical Systems Corporation, Christie Medical Holdings Inc., Fujifilm Healthcare Corporation, Esaote SpA, Mindray Medical International Limited, Ziehm Imaging GmbH, Samsung Medison Co. Ltd., United Imaging Healthcare.
North America was the largest region in the vascular imaging devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular imaging devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vascular imaging devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the vascular imaging devices market by increasing costs of imported sensors, imaging probes, semiconductor chips, high-resolution displays, and advanced computing components. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported high-end imaging systems, while Asia-Pacific faces cost pressures on device manufacturing and exports. These tariffs are elevating equipment acquisition costs and delaying technology upgrades. However, they are also promoting local assembly, regional manufacturing partnerships, and increased investment in domestic imaging technology capabilities.
The vascular imaging devices market research report is one of a series of new reports that provides vascular imaging devices market statistics, including vascular imaging devices industry global market size, regional shares, competitors with a vascular imaging devices market share, detailed vascular imaging devices market segments, market trends and opportunities, and any further data you may need to thrive in the vascular imaging devices industry. This vascular imaging devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Vascular imaging devices are medical tools that employ non-invasive techniques to visualize blood vessels and the circulatory system. They use various technologies to produce detailed images of the vascular network, assisting in the diagnosis and treatment of cardiovascular issues.
The primary categories of vascular imaging devices are minimally invasive and non-invasive. Minimally invasive procedures involve small incisions or catheters to access internal structures for diagnostic or therapeutic purposes. These devices are used in a range of applications, including diagnostics and treatment, serving end-users such as hospitals, diagnostic imaging centers, and other medical facilities.
The vascular imaging devices market consists of sales of angiography systems, intravascular ultrasound systems, high-speed computed tomography systems, and portable doppler devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Vascular Imaging Devices Market Characteristics
3. Vascular Imaging Devices Market Supply Chain Analysis
4. Global Vascular Imaging Devices Market Trends and Strategies
5. Vascular Imaging Devices Market Analysis of End Use Industries
7. Global Vascular Imaging Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Vascular Imaging Devices Total Addressable Market (TAM) Analysis for the Market
9. Vascular Imaging Devices Market Segmentation
10. Vascular Imaging Devices Market Regional and Country Analysis
11. Asia-Pacific Vascular Imaging Devices Market
12. China Vascular Imaging Devices Market
13. India Vascular Imaging Devices Market
14. Japan Vascular Imaging Devices Market
15. Australia Vascular Imaging Devices Market
16. Indonesia Vascular Imaging Devices Market
17. South Korea Vascular Imaging Devices Market
18. Taiwan Vascular Imaging Devices Market
19. South East Asia Vascular Imaging Devices Market
20. Western Europe Vascular Imaging Devices Market
21. UK Vascular Imaging Devices Market
22. Germany Vascular Imaging Devices Market
23. France Vascular Imaging Devices Market
24. Italy Vascular Imaging Devices Market
25. Spain Vascular Imaging Devices Market
26. Eastern Europe Vascular Imaging Devices Market
27. Russia Vascular Imaging Devices Market
28. North America Vascular Imaging Devices Market
29. USA Vascular Imaging Devices Market
30. Canada Vascular Imaging Devices Market
31. South America Vascular Imaging Devices Market
32. Brazil Vascular Imaging Devices Market
33. Middle East Vascular Imaging Devices Market
34. Africa Vascular Imaging Devices Market
36. Vascular Imaging Devices Market Competitive Landscape and Company Profiles
37. Vascular Imaging Devices Market Other Major and Innovative Companies
40. Vascular Imaging Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Vascular Imaging Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses vascular imaging devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for vascular imaging devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vascular imaging devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Minimally Invasive; Non-Invasive2) By Application: Diagnostics; Therapeutics
3) By End-User: Hospitals; Diagnostic Imaging Centers; Other End Users
Subsegments:
1) By Minimally Invasive: Intravascular Ultrasound (IVUS); Optical Coherence Tomography (OCT); Angiography (Including Catheter-Based Angiography)2) By Non-Invasive: Magnetic Resonance Angiography (MRA); Computed Tomography Angiography (CTA); Doppler Ultrasound; Color Flow Duplex Ultrasound; Contrast-Enhanced Ultrasound; Photoacoustic Imaging
Companies Mentioned: Abbott Laboratories; Medtronic plc; Siemens Healthineers AG; Koninklijke Philips N.V.; GE Healthcare Technologies Inc.; Terumo Corporation; Nipro Corporation; Shimadzu Corporation; Bracco Group; Carestream Health Inc.; Hitachi Medical Corporation; Canon Medical Systems Corporation; Toshiba Medical Systems Corporation; Christie Medical Holdings Inc.; Fujifilm Healthcare Corporation; Esaote SpA; Mindray Medical International Limited; Ziehm Imaging GmbH; Samsung Medison Co. Ltd.; United Imaging Healthcare
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Vascular Imaging Devices market report include:- Abbott Laboratories
- Medtronic plc
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- GE Healthcare Technologies Inc.
- Terumo Corporation
- Nipro Corporation
- Shimadzu Corporation
- Bracco Group
- Carestream Health Inc.
- Hitachi Medical Corporation
- Canon Medical Systems Corporation
- Toshiba Medical Systems Corporation
- Christie Medical Holdings Inc.
- Fujifilm Healthcare Corporation
- Esaote SpA
- Mindray Medical International Limited
- Ziehm Imaging GmbH
- Samsung Medison Co. Ltd.
- United Imaging Healthcare
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 8.89 Billion |
| Forecasted Market Value ( USD | $ 11.12 Billion |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
